Northwestern Mutual Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.86M | Buy |
9,815
+6,351
| +183% | +$1.11M | ﹤0.01% | 1128 |
|
|
2025
Q4 | $589K | Buy |
3,464
+133
| +4% | +$20.4K | ﹤0.01% | 1474 |
|
|
2025
Q3 | $439K | Buy |
3,331
+556
| +20% | +$66.7K | ﹤0.01% | 1506 |
|
|
2025
Q2 | $294K | Sell |
2,775
-659
| -19% | -$71.6K | ﹤0.01% | 1590 |
|
|
2025
Q1 | $426K | Buy |
3,434
+606
| +21% | +$79.1K | ﹤0.01% | 1393 |
|
|
2024
Q4 | $348K | Buy |
2,828
+893
| +46% | +$105K | ﹤0.01% | 1446 |
|
|
2024
Q3 | $216K | Buy |
1,935
+32
| +2% | +$3.51K | ﹤0.01% | 1601 |
|
|
2024
Q2 | $203K | Buy |
1,903
+13
| +0.7% | +$1.43K | ﹤0.01% | 1559 |
|
|
2024
Q1 | $228K | Hold |
1,890
| – | – | ﹤0.01% | 1505 |
|
|
2023
Q4 | $232K | Buy |
1,890
+227
| +14% | +$28.3K | ﹤0.01% | 1455 |
|
|
2023
Q3 | $215K | Buy |
1,663
+9
| +0.5% | +$1.2K | ﹤0.01% | 1436 |
|
|
2023
Q2 | $205K | Sell |
1,654
-297
| -15% | -$40K | ﹤0.01% | 1451 |
|
|
2023
Q1 | $285K | Sell |
1,951
-469
| -19% | -$69.4K | ﹤0.01% | 1317 |
|
|
2022
Q4 | $386K | Sell |
2,420
-81
| -3% | -$11.9K | ﹤0.01% | 1192 |
|
|
2022
Q3 | $333K | Sell |
2,501
-150
| -6% | -$22.8K | ﹤0.01% | 1210 |
|
|
2022
Q2 | $413K | Sell |
2,651
-46
| -2% | -$7.08K | ﹤0.01% | 1121 |
|
|
2022
Q1 | $419K | Sell |
2,697
-38
| -1% | -$5.51K | ﹤0.01% | 1147 |
|
|
2021
Q4 | $348K | Buy |
2,735
+35
| +1% | +$4.6K | ﹤0.01% | 1230 |
|
|
2021
Q3 | $352K | Sell |
2,700
-33
| -1% | -$4.99K | ﹤0.01% | 1126 |
|
|
2021
Q2 | $485K | Buy |
2,733
+58
| +2% | +$10K | ﹤0.01% | 995 |
|
|
2021
Q1 | $440K | Sell |
2,675
-46
| -2% | -$7.57K | ﹤0.01% | 967 |
|
|
2020
Q4 | $450K | Hold |
2,721
| – | – | ﹤0.01% | 865 |
|
|
2020
Q3 | $388K | Sell |
2,721
-3,348
| -55% | -$415K | ﹤0.01% | 823 |
|
|
2020
Q2 | $669K | Buy |
6,069
+5,317
| +707% | +$588K | ﹤0.01% | 630 |
|
|
2020
Q1 | $76K | Buy |
752
+707
| +1,571% | +$91.4K | ﹤0.01% | 1213 |
|
|
2019
Q4 | $6K | Buy |
45
+40
| +800% | +$5.44K | ﹤0.01% | 2031 |
|
|
2019
Q3 | $1K | Buy |
+5
| New | +$670 | ﹤0.01% | 2359 |
|
|
2018
Q4 | – | Sell |
-6
| Closed | -$1K | – | 2510 |
|
|
2018
Q3 | $1K | Sell |
6
-9
| -60% | -$1.55K | ﹤0.01% | 2377 |
|
|
2018
Q2 | $3K | Sell |
15
-227
| -94% | -$37.1K | ﹤0.01% | 2098 |
|
|
2018
Q1 | $37K | Sell |
242
-11
| -4% | -$1.61K | ﹤0.01% | 1318 |
|
|
2017
Q4 | $34K | Buy |
253
+66
| +35% | +$9.15K | ﹤0.01% | 1293 |
|
|
2017
Q3 | $27K | Sell |
187
-38
| -17% | -$5.75K | ﹤0.01% | 1362 |
|
|
2017
Q2 | $35K | Sell |
225
-41
| -15% | -$6.27K | ﹤0.01% | 1206 |
|
|
2017
Q1 | $39K | Sell |
266
-33
| -11% | -$4.3K | ﹤0.01% | 1099 |
|
|
2016
Q4 | $33K | Buy |
+299
| New | +$33.3K | ﹤0.01% | 1167 |
|
|
2016
Q3 | – | Sell |
-207
| Closed | -$29K | – | 873 |
|
|
2016
Q2 | $29K | Sell |
207
-8
| -4% | -$1.18K | ﹤0.01% | 1045 |
|
|
2016
Q1 | $28K | Buy |
215
+160
| +291% | +$19.9K | ﹤0.01% | 1071 |
|
|
2015
Q4 | $8K | Sell |
55
-4
| -7% | -$554 | ﹤0.01% | 1218 |
|
|
2015
Q3 | $8K | Buy |
+59
| New | +$10.2K | ﹤0.01% | 1136 |
|
|
2015
Q1 | – | Sell |
-50
| Closed | -$8K | – | 1676 |
|
|
2014
Q4 | $8K | Sell |
50
-87
| -64% | -$14.4K | ﹤0.01% | 1145 |
|
|
2014
Q3 | $22K | Buy |
137
+100
| +270% | +$15.4K | ﹤0.01% | 801 |
|
|
2014
Q2 | $5K | Hold |
37
| – | – | ﹤0.01% | 1021 |
|
|
2014
Q1 | $5K | Hold |
37
| – | – | ﹤0.01% | 985 |
|
|
2013
Q4 | $5K | Hold |
37
| – | – | ﹤0.01% | 1056 |
|
|
2013
Q3 | $3K | Buy |
+37
| New | +$2.98K | ﹤0.01% | 1096 |
|
Other funds holding JAZZ
VPM
VCM
EC
Northwestern Mutual Wealth Management's JAZZ Position: Q1 2026 in Review
Northwestern Mutual Wealth Management increased its Jazz Pharmaceuticals (JAZZ) stake by 183% in Q1 2026, buying an estimated $1.11M and bringing the position to 9,815 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1128.
Northwestern Mutual Wealth Management first reported a position in JAZZ in Q3 2013 and has held it in 45 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Northwestern Mutual Wealth Management held 9,815 shares of Jazz Pharmaceuticals worth $1.86M as of Q1 2026.
- Northwestern Mutual Wealth Management bought 6,351 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.11M.
- Jazz Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #1128 holding.
- Northwestern Mutual Wealth Management first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 45 quarters since.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.